ENTITY
Kintor Pharmaceutical

Kintor Pharmaceutical (9939 HK)

66
Analysis
Health CareChina
Kintor Pharmaceutical Limited develops and markets drugs. The Company produces and sells androgen receptor antagonists, small molecule innovative drugs, and other products. Kintor Pharmaceutical markets its products primarily throughout China with limited overseas.
more
Refresh
09 Jul 2023 09:48

China Healthcare Weekly (Jul.7) - New NRDL Negotiation Rules, Assisted Reproduction Payment, Kintor

Investors should not be overly optimistic about the new NRDL negotiation rule of innovative drug. Assisted reproduction technology will be covered...

Logo
427 Views
Share
17 Jun 2021 09:16

Industry Report - Insights on Hair Loss Prevention and Hair Growth Industry

This article analyzed China hair loss prevention and hair growth industry in terms of the market potential, the hair loss drugs, the hair...

Logo
232 Views
Share
04 Apr 2024 12:45

Hong Kong Connect Flows (Mar): 12 Month High of $9.8bn Inflows

We analyzed the Hong Kong Connect Scheme for March and highlight flows for Bank of China, Tencent, China Mobile, CNOOC, ZTO, Anta.

Logo
295 Views
Share
bullishPegBio
11 Mar 2024 02:27

PegBio IPO Preview: A Founder-Led Biopharma Player Fighting T2DM and Obesity in China

PegBio, a promising founder-led biotech company, is seeking to tap capital markets in Hong Kong. Their core product for the treatment of T2DM is at...

Logo
299 Views
Share
05 Mar 2024 21:59

Hong Kong Connect Flows (February): CNOOC, China Telecom, China Mobile, Li Auto, Meituan

​Analysis of monthly Hong Kong Connect flows reveals top stocks attracting mainland investors, including CNOOC, China Telecom, China Mobile, Li...

Logo
355 Views
Share
x